Singapore’s Travecta Therapeutics secures $15m in Series A funding

Photo: Pixabay

Singapore-based biopharmaceutical company Travecta Therapeutics said Tuesday it has secured $15 million in its Series A round of financing, led by TKS1, a life science focused venture capital fund formed by life science consulting agency SPRIM and asset management company Tikehau Capital.

Travecta is developing a broad portfolio of product candidates engineered to cross the blood-brain-barrier.

The proceeds from the Series A financing will be used to support Travecta’s growth and advance the development of TVT-004, the company’s lead non-opioid product targeting pain, according to a company statement.

The company plans to enter clinical trials in 2021. The funding will also support the progression of its earlier stage research programmes in neuro-oncology and neuro-inflammation.

The company’s proprietary mVECTA platform allows it to screen and develop product candidates that can cross the blood-brain barrier targeting novel and untapped neurological pathways.

“Our mVECTA platform technology is unlocking key biological targets in neurological diseases that were previously difficult to engage because of the blood-brain barrier,” said chief scientific officer Dr Mahmood Ahmed.

“We are thankful to our partners to support our vision and develop therapies that can potentially transform how neurological conditions, many of which are without FDA approved drugs, are treated,” Travecta Therapeutics CEO Dr. Michael Shleifer said.

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.